Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,080 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Peptide intra-tumor injection for cancer immunotherapy: enhancement of tumor cell antigenicity is a novel and attractive strategy.
Nobuoka D, Yoshikawa T, Fujiwara T, Nakatsura T. Nobuoka D, et al. Among authors: yoshikawa t. Hum Vaccin Immunother. 2013 Jun;9(6):1234-6. doi: 10.4161/hv.23990. Epub 2013 Feb 14. Hum Vaccin Immunother. 2013. PMID: 23411443 Free PMC article. Review.
HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells.
Yoshikawa T, Nakatsugawa M, Suzuki S, Shirakawa H, Nobuoka D, Sakemura N, Motomura Y, Tanaka Y, Hayashi S, Nakatsura T. Yoshikawa T, et al. Cancer Sci. 2011 May;102(5):918-25. doi: 10.1111/j.1349-7006.2011.01896.x. Epub 2011 Mar 4. Cancer Sci. 2011. PMID: 21281401 Clinical Trial.
Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.
Suzuki S, Yoshikawa T, Hirosawa T, Shibata K, Kikkawa F, Akatsuka Y, Nakatsura T. Suzuki S, et al. Among authors: yoshikawa t. Cancer Sci. 2011 Sep;102(9):1622-9. doi: 10.1111/j.1349-7006.2011.02003.x. Epub 2011 Jul 8. Cancer Sci. 2011. PMID: 21668581
Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, Lengsin.
Nakatsugawa M, Horie K, Yoshikawa T, Shimomura M, Kikuchi Y, Sakemura N, Suzuki S, Nobuoka D, Hirohashi Y, Torigoe T, Harada K, Takasu H, Sato N, Nakatsura T. Nakatsugawa M, et al. Among authors: yoshikawa t. Int J Oncol. 2011 Oct;39(4):1041-9. doi: 10.3892/ijo.2011.1089. Epub 2011 Jun 17. Int J Oncol. 2011. PMID: 21687943
Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes.
Nobuoka D, Motomura Y, Shirakawa H, Yoshikawa T, Kuronuma T, Takahashi M, Nakachi K, Ishii H, Furuse J, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kinoshita T, Komori H, Baba H, Fujiwara T, Nakatsura T. Nobuoka D, et al. Among authors: yoshikawa t. Int J Oncol. 2012 Jan;40(1):63-70. doi: 10.3892/ijo.2011.1202. Epub 2011 Sep 15. Int J Oncol. 2012. PMID: 21922136 Clinical Trial.
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival.
Sawada Y, Yoshikawa T, Nobuoka D, Shirakawa H, Kuronuma T, Motomura Y, Mizuno S, Ishii H, Nakachi K, Konishi M, Nakagohri T, Takahashi S, Gotohda N, Takayama T, Yamao K, Uesaka K, Furuse J, Kinoshita T, Nakatsura T. Sawada Y, et al. Among authors: yoshikawa t. Clin Cancer Res. 2012 Jul 1;18(13):3686-96. doi: 10.1158/1078-0432.CCR-11-3044. Epub 2012 May 10. Clin Cancer Res. 2012. PMID: 22577059 Clinical Trial.
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.
Nobuoka D, Yoshikawa T, Takahashi M, Iwama T, Horie K, Shimomura M, Suzuki S, Sakemura N, Nakatsugawa M, Sadamori H, Yagi T, Fujiwara T, Nakatsura T. Nobuoka D, et al. Among authors: yoshikawa t. Cancer Immunol Immunother. 2013 Apr;62(4):639-52. doi: 10.1007/s00262-012-1366-6. Epub 2012 Nov 11. Cancer Immunol Immunother. 2013. PMID: 23143746 Free PMC article.
A glypican-3-derived peptide vaccine against hepatocellular carcinoma.
Sawada Y, Sakai M, Yoshikawa T, Ofuji K, Nakatsura T. Sawada Y, et al. Among authors: yoshikawa t. Oncoimmunology. 2012 Nov 1;1(8):1448-1450. doi: 10.4161/onci.21351. Oncoimmunology. 2012. PMID: 23243625 Free PMC article.
Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide.
Iwama T, Horie K, Yoshikawa T, Nobuoka D, Shimomura M, Sawada Y, Nakatsura T. Iwama T, et al. Among authors: yoshikawa t. Int J Oncol. 2013 Mar;42(3):831-8. doi: 10.3892/ijo.2013.1793. Epub 2013 Jan 23. Int J Oncol. 2013. PMID: 23354275 Free PMC article.
Peptide vaccines for hepatocellular carcinoma.
Nobuoka D, Yoshikawa T, Sawada Y, Fujiwara T, Nakatsura T. Nobuoka D, et al. Among authors: yoshikawa t. Hum Vaccin Immunother. 2013 Jan;9(1):210-2. doi: 10.4161/hv.22473. Hum Vaccin Immunother. 2013. PMID: 23442593 Free PMC article.
4,080 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback